605177 东亚药业
交易中 09-16 14:11:38
资讯
新帖
简况
股市必读:东亚药业新发布《东亚药业关于股票交易异常波动的公告》
证券之星 · 09-14 01:53
股市必读:东亚药业新发布《东亚药业关于股票交易异常波动的公告》
东亚药业(605177)披露股票交易异常波动公告,9月10日股价上涨8.47%
证券之星 · 09-10
东亚药业(605177)披露股票交易异常波动公告,9月10日股价上涨8.47%
股市必读:东亚药业(605177)登9月8日交易所龙虎榜
证券之星 · 09-09
股市必读:东亚药业(605177)登9月8日交易所龙虎榜
异动快报:东亚药业(605177)9月8日10点26分触及涨停板
证券之星 · 09-08
异动快报:东亚药业(605177)9月8日10点26分触及涨停板
9月7日东亚药业(605177)龙虎榜数据
证券之星 · 09-07
9月7日东亚药业(605177)龙虎榜数据
每周股票复盘:东亚药业(605177)股东户数减少13.24%,净利亏损1.18亿
证券之星 · 09-06
每周股票复盘:东亚药业(605177)股东户数减少13.24%,净利亏损1.18亿
东亚药业(605177)8月31日股东户数1万户,较上期减少13.24%
证券之星 · 09-03
东亚药业(605177)8月31日股东户数1万户,较上期减少13.24%
东亚药业:截至2026年8月31日,公司股东人数为9988户
证券之星 · 09-03
东亚药业:截至2026年8月31日,公司股东人数为9988户
股市必读:东亚药业新发布《东亚药业关于2026年半年度计提资产减值准备的公告》
证券之星 · 09-01
股市必读:东亚药业新发布《东亚药业关于2026年半年度计提资产减值准备的公告》
东亚药业(605177)披露2026年半年度报告,8月31日股价上涨1.03%
证券之星 · 08-31
东亚药业(605177)披露2026年半年度报告,8月31日股价上涨1.03%
图解东亚药业中报:第二季度单季净利润同比下降256.84%
证券之星 · 08-30
图解东亚药业中报:第二季度单季净利润同比下降256.84%
每周股票复盘:东亚药业(605177)股东户数增11.21%,回购1.45万股
证券之星 · 08-30
每周股票复盘:东亚药业(605177)股东户数增11.21%,回购1.45万股
东亚药业(605177)披露部分限制性股票回购注销完成不调整可转债转股价格公告,8月24日股价下跌0.43%
证券之星 · 08-24
东亚药业(605177)披露部分限制性股票回购注销完成不调整可转债转股价格公告,8月24日股价下跌0.43%
东亚药业:坚定推进原料药制剂一体化
证券之星 · 08-21
东亚药业:坚定推进原料药制剂一体化
每周股票复盘:东亚药业(605177)股东户数减少2.25%,户均持股市值19.28万元
证券之星 · 08-16
每周股票复盘:东亚药业(605177)股东户数减少2.25%,户均持股市值19.28万元
股市必读:东亚药业(605177)股东户数1.04万户,较上期减少2.25%
证券之星 · 08-14
股市必读:东亚药业(605177)股东户数1.04万户,较上期减少2.25%
东亚药业:截至2026年8月10日,公司股东人数为10352户
证券之星 · 08-13
东亚药业:截至2026年8月10日,公司股东人数为10352户
每周股票复盘:东亚药业(605177)股东户数较上期减少158.0户
证券之星 · 08-09
每周股票复盘:东亚药业(605177)股东户数较上期减少158.0户
东亚药业(605177)7月31日股东户数1.06万户,较上期减少1.47%
证券之星 · 08-05
东亚药业(605177)7月31日股东户数1.06万户,较上期减少1.47%
东亚药业:截至2026年7月20日,公司股东人数为10748户
证券之星 · 07-21
东亚药业:截至2026年7月20日,公司股东人数为10748户
暂无数据
公司概况
公司名称:
浙江东亚药业股份有限公司
所属行业:
医药制造业
上市日期:
2020-11-25
主营业务:
浙江东亚药业股份有限公司的主营业务是化学原料药、医药中间体、化学制剂的研发、生产和销售业务。公司的主要产品是抗细菌类药物(β-内酰胺类和喹诺酮类)、消化系统药物、皮肤用抗真菌药物等。公司在浙江三门、浙江临海、江西九江建有一体化的制药基地,并在上海张江药谷、杭州下沙医药港小镇设有现代化的研发中心,先后获得“国家高新技术企业”“浙江省专利示范企业”“台州市管理创新十强企业”等称号。
发行价格:
31.13
{"stockData":{"symbol":"605177","market":"SH","secType":"STK","nameCN":"东亚药业","latestPrice":24.84,"timestamp":1789539098000,"preClose":24.9,"halted":0,"volume":9340781,"delay":0,"changeRate":-0.0024,"floatShares":113999999,"shares":114999999,"eps":-1.4868,"marketStatus":"交易中","change":-0.06,"latestTime":"09-16 14:11:38","open":24.64,"high":25.25,"low":23.02,"amount":226000000,"amplitude":0.0896,"askPrice":24.85,"askSize":24,"bidPrice":24.84,"bidSize":3,"shortable":0,"etf":0,"ttmEps":-1.4868,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1789542000000},"marketStatusCode":2,"adr":0,"adjPreClose":24.9,"symbolType":"stock","openAndCloseTimeList":[[1789522200000,1789529400000],[1789534800000,1789542000000]],"highLimit":27.39,"lowLimit":22.41,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":114705914,"isCdr":false,"pbRate":1.8,"roa":"--","roe":"--","epsLYR":-0.72,"committee":0.099415,"marketValue":2849000000,"turnoverRate":0.0822,"status":1,"floatMarketCap":2823000000},"requestUrl":"/m/hq/s/605177/tweets","defaultTab":"tweets","newsList":[{"id":"2667680604","title":"股市必读:东亚药业新发布《东亚药业关于股票交易异常波动的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667680604","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667680604?lang=zh_cn&edition=full","pubTime":"2026-09-14 01:53","pubTimestamp":1789321989,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘,东亚药业报收于23.57元,下跌4.61%,换手率11.59%,成交量13.17万手,成交额3.07亿元。公司公告汇总:东亚药业股票于9月8日至10日连续三个交易日收盘价涨幅偏离值累计达20%,触发异常波动;公司披露2026年半年度净利润为-118,376,942.74元,自2024年度以来连续亏损。经公司自查并书面问询控股股东及实际控制人,截至公告披露日,不存在应披露而未披露的重大事项。公司提醒投资者注意二级市场交易风险及业绩亏损带来的投资风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400000752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666591889","title":"东亚药业(605177)披露股票交易异常波动公告,9月10日股价上涨8.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666591889","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666591889?lang=zh_cn&edition=full","pubTime":"2026-09-10 22:08","pubTimestamp":1789049299,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘,东亚药业报收于24.71元,较前一交易日上涨8.47%,最新总市值为28.34亿元。近日,东亚药业发布《关于股票交易异常波动的公告》。公告显示,公司股票于2026年9月8日、9月9日、9月10日连续三个交易日内日收盘价格涨幅偏离值累计达20%,属于股票交易异常波动情形。经公司自查并书面问询控股股东及实际控制人,截至公告披露日,不存在应披露而未披露的重大事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000041870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374935","title":"股市必读:东亚药业(605177)登9月8日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374935","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666374935?lang=zh_cn&edition=full","pubTime":"2026-09-09 00:47","pubTimestamp":1788886031,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘,东亚药业报收于22.06元,上涨10.02%,涨停,换手率9.69%,成交量11.02万手,成交额2.3亿元。交易信息汇总:东亚药业因日收盘价格涨幅偏离值达7%,登上沪深交易所9月8日龙虎榜,系近5个交易日内第2次上榜。公司公告汇总:东亚药业将于2026年9月15日10:30–11:30通过价值在线平台召开2026年半年度业绩说明会,董事长兼总经理池骋、独立董事冯燕、财务负责人王小敏、董事会秘书周剑波将出席。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900001987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665034139","title":"异动快报:东亚药业(605177)9月8日10点26分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2665034139","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665034139?lang=zh_cn&edition=full","pubTime":"2026-09-08 10:31","pubTimestamp":1788834693,"startTime":"0","endTime":"0","summary":"证券之星9月8日盘中消息,10点26分东亚药业(605177)触及涨停板。其所属行业化学制药目前上涨。领涨股为纳微科技。该股为化学原料药,阿尔茨海默病,医药概念热股,当日化学原料药概念上涨0.23%,阿尔茨海默病概念上涨0.21%,医药概念上涨0.06%。9月7日的资金流向数据方面,主力资金净流出138.13万元,占总成交额0.39%,游资资金净流入479.1万元,占总成交额1.35%,散户资金净流出340.97万元,占总成交额0.96%。近5日资金流向一览见下表:东亚药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800011281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665199314","title":"9月7日东亚药业(605177)龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2665199314","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665199314?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:54","pubTimestamp":1788774861,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年9月7日公布的交易公开信息显示,东亚药业因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年9月7日收盘,东亚药业报收于20.05元,下跌8.74%,换手率15.14%,成交量17.21万手,成交额3.54亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700023566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365577","title":"每周股票复盘:东亚药业(605177)股东户数减少13.24%,净利亏损1.18亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365577","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665365577?lang=zh_cn&edition=full","pubTime":"2026-09-06 01:38","pubTimestamp":1788629892,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,东亚药业报收于21.97元,较上周的21.45元上涨2.42%。本周,东亚药业9月4日盘中最高价报25.1元,股价触及近一年最高点。东亚药业当前最新总市值25.2亿元,在化学制药板块市值排名138/149,在两市A股市值排名4742/5214。本周关注点股本股东变化:股东户数较8月20日减少13.24%。户均持股数量由上期的9965.0股上升至1.15万股,户均持股市值为24.89万元。本次计提减少公司合并报表利润总额6,771.31万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878034","title":"东亚药业(605177)8月31日股东户数1万户,较上期减少13.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878034","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664878034?lang=zh_cn&edition=full","pubTime":"2026-09-03 17:29","pubTimestamp":1788427781,"startTime":"0","endTime":"0","summary":"证券之星消息,近日东亚药业披露,截至2026年8月31日公司股东户数为9988.0户,较8月20日减少1524.0户,减幅为13.24%。在化学制药行业个股中,东亚药业股东户数低于行业平均水平,截至8月31日,化学制药行业平均股东户数为3.66万户。从股价来看,2026年8月20日至2026年8月31日,东亚药业区间涨幅为4.33%,在此期间股东户数减少1524.0户,减幅为13.24%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300031458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664623822","title":"东亚药业:截至2026年8月31日,公司股东人数为9988户","url":"https://stock-news.laohu8.com/highlight/detail?id=2664623822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664623822?lang=zh_cn&edition=full","pubTime":"2026-09-03 15:33","pubTimestamp":1788420788,"startTime":"0","endTime":"0","summary":"证券之星消息,东亚药业(605177)09月03日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2026年8月31日,公司股东人数多少?东亚药业回复:尊敬的投资者,您好!截至2026年8月31日,公司股东人数为9988户。感谢您对公司的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300023284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664009770","title":"股市必读:东亚药业新发布《东亚药业关于2026年半年度计提资产减值准备的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664009770","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664009770?lang=zh_cn&edition=full","pubTime":"2026-09-01 02:47","pubTimestamp":1788202030,"startTime":"0","endTime":"0","summary":"公司公告汇总:2026年半年度计提资产减值准备合计6,771.31万元,减少合并报表利润总额6,771.31万元。东亚药业2026年半年度报告摘要截至2026年6月30日,公司总资产为3,068,107,266.70元,较上年度末减少8.08%;归属于上市公司股东的净资产为1,703,469,373.15元,较上年度末减少5.67%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100002519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663807245","title":"东亚药业(605177)披露2026年半年度报告,8月31日股价上涨1.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663807245","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663807245?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:54","pubTimestamp":1788173656,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘,东亚药业报收于21.67元,较前一交易日上涨1.03%,最新总市值为24.86亿元。该股当日开盘21.09元,最高21.67元,最低20.78元,成交额达8414.3万元,换手率为3.48%。近日,东亚药业披露《2026年半年度报告》。公告显示,截至报告期末,公司总资产为3,068,107,266.70元,较上年度末减少8.08%;归属于上市公司股东的净资产为1,703,469,373.15元,较上年度末减少5.67%。公司2026年上半年不进行利润分配,也不进行公积金转增股本。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100029759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663490240","title":"图解东亚药业中报:第二季度单季净利润同比下降256.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663490240","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663490240?lang=zh_cn&edition=full","pubTime":"2026-08-30 17:40","pubTimestamp":1788082854,"startTime":"0","endTime":"0","summary":"证券之星消息,东亚药业2026年中报显示,上半年度公司主营收入4.66亿元,同比上升12.09%;归母净利润-1.18亿元,同比下降291.61%;扣非净利润-1.24亿元,同比下降244.29%;其中2026年第二季度,公司单季度主营收入2.02亿元,同比下降10.39%;单季度归母净利润-8317.53万元,同比下降256.84%;单季度扣非净利润-8489.74万元,同比下降234.57%;负债率44.48%,投资收益216.7万元,财务费用1798.91万元,毛利率23.88%。财报数据概要请见下图:本文数据来源于东亚药业2026年中报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000012897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663048868","title":"每周股票复盘:东亚药业(605177)股东户数增11.21%,回购1.45万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663048868","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663048868?lang=zh_cn&edition=full","pubTime":"2026-08-30 04:57","pubTimestamp":1788037028,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,东亚药业报收于21.45元,较上周的20.73元上涨3.47%。股本股东变化股东户数变动截至2026年8月20日,东亚药业股东户数为1.15万户,较8月10日增加1160户,增幅11.21%。东亚药业关于股权激励部分限制性股票回购注销实施公告因2名激励对象主动辞职,不再具备激励对象资格,公司拟回购注销其已获授但尚未解除限售的限制性股票合计14,500股。本次注销后,公司总股本相应减少,剩余股权激励限制性股票为1,053,551股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661485220","title":"东亚药业(605177)披露部分限制性股票回购注销完成不调整可转债转股价格公告,8月24日股价下跌0.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661485220","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661485220?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:13","pubTimestamp":1787566405,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘,东亚药业报收于20.64元,较前一交易日下跌0.43%,最新总市值为23.68亿元。东亚药业于近日披露《关于部分限制性股票回购注销完成不调整可转债转股价格的公告》。公告显示,公司因回购注销2名激励对象持有的14,500股限制性股票,占总股本比例较小,根据可转债募集说明书约定的转股价格调整公式计算,本次回购注销完成后,东亚转债转股价格保持20.28元/股不变。公司已向上证所提交相关注销申请,预计于2026年8月26日完成注销。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400026067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661075265","title":"东亚药业:坚定推进原料药制剂一体化","url":"https://stock-news.laohu8.com/highlight/detail?id=2661075265","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661075265?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:57","pubTimestamp":1787302653,"startTime":"0","endTime":"0","summary":"证券之星消息,东亚药业08月21日在投资者关系平台上答复投资者关心的问题。公司对未来做出了什么规划路线和创新举措东亚药业回复:尊敬的投资者,您好!公司长期深耕医药中间体和原料药行业,同时在上市后实施“以原料药为中心,往前伸、向后延”的一体化战略。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100030011.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659176845","title":"每周股票复盘:东亚药业(605177)股东户数减少2.25%,户均持股市值19.28万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2659176845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659176845?lang=zh_cn&edition=full","pubTime":"2026-08-16 02:37","pubTimestamp":1786819030,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘,东亚药业报收于18.57元,较上周的16.77元上涨10.73%。本周,东亚药业8月14日盘中最高价报19.68元。东亚药业当前最新总市值21.3亿元,在化学制药板块市值排名144/149,在两市A股市值排名4926/5207。本周关注点股本股东变化:股东户数减少2.25%,户均持股市值为19.28万元股本股东变化股东户数变动截至2026年8月10日,公司股东户数为1.04万户,较7月31日减少238.0户,减幅为2.25%。户均持股数量由上期的1.08万股上升至1.11万股,户均持股市值为19.28万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659169966","title":"股市必读:东亚药业(605177)股东户数1.04万户,较上期减少2.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659169966","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659169966?lang=zh_cn&edition=full","pubTime":"2026-08-14 01:05","pubTimestamp":1786640714,"startTime":"0","endTime":"0","summary":"截至2026年8月13日收盘,东亚药业报收于18.61元,上涨5.68%,换手率4.31%,成交量4.9万手,成交额8944.7万元。股本股东变化:截至2026年8月10日,东亚药业股东户数为1.04万户,较7月31日减少238户,减幅2.25%。户均持股数量由上期的1.08万股增加至1.11万股,户均持股市值为19.28万元。截至2026年8月10日,公司股东人数为10352户。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400000760.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659131772","title":"东亚药业:截至2026年8月10日,公司股东人数为10352户","url":"https://stock-news.laohu8.com/highlight/detail?id=2659131772","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659131772?lang=zh_cn&edition=full","pubTime":"2026-08-13 15:33","pubTimestamp":1786606427,"startTime":"0","endTime":"0","summary":"证券之星消息,东亚药业(605177)08月13日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2026年8月10日,公司股东人数多少?东亚药业回复:尊敬的投资者,您好!截至2026年8月10日,公司股东人数为10352户。感谢您对公司的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300020210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658675160","title":"每周股票复盘:东亚药业(605177)股东户数较上期减少158.0户","url":"https://stock-news.laohu8.com/highlight/detail?id=2658675160","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658675160?lang=zh_cn&edition=full","pubTime":"2026-08-09 03:07","pubTimestamp":1786216032,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,东亚药业报收于16.77元,较上周的15.65元上涨7.16%。本周,东亚药业8月5日盘中最高价报16.97元。8月3日盘中最低价报15.61元。东亚药业当前最新总市值19.24亿元,在化学制药板块市值排名145/149,在两市A股市值排名5023/5205。本周关注点股本股东变化:股东户数较上期减少158.0户股本股东变化:户均持股市值为16.95万元股本股东变化股东户数变动截至2026年7月31日,公司股东户数为1.06万户,较7月20日减少158.0户,减幅为1.47%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900001044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657517750","title":"东亚药业(605177)7月31日股东户数1.06万户,较上期减少1.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657517750","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657517750?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:43","pubTimestamp":1785922984,"startTime":"0","endTime":"0","summary":"证券之星消息,近日东亚药业披露,截至2026年7月31日公司股东户数为1.06万户,较7月20日减少158.0户,减幅为1.47%。在化学制药行业个股中,东亚药业股东户数低于行业平均水平,截至7月31日,化学制药行业平均股东户数为3.59万户。从股价来看,2026年7月20日至2026年7月31日,东亚药业区间涨幅为3.92%,在此期间股东户数减少158.0户,减幅为1.47%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500032377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653271222","title":"东亚药业:截至2026年7月20日,公司股东人数为10748户","url":"https://stock-news.laohu8.com/highlight/detail?id=2653271222","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653271222?lang=zh_cn&edition=full","pubTime":"2026-07-21 16:12","pubTimestamp":1784621542,"startTime":"0","endTime":"0","summary":"证券之星消息,东亚药业(605177)07月21日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2026年7月20日,公司股东人数多少?东亚药业回复:尊敬的投资者,您好!截至2026年7月20日,公司股东人数为10748户。感谢您对公司的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100029546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789539106092,"stockEarnings":[{"period":"1week","weight":0.1287},{"period":"1month","weight":0.3409},{"period":"3month","weight":0.3934},{"period":"6month","weight":0.1751},{"period":"1year","weight":0.2544},{"period":"ytd","weight":0.3989}],"compareEarnings":[{"period":"1week","weight":-0.0194},{"period":"1month","weight":-0.016},{"period":"3month","weight":-0.0593},{"period":"6month","weight":-0.0355},{"period":"1year","weight":0.001},{"period":"ytd","weight":-0.0263}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江东亚药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"9988人(较上一季度减少13.24%)","perCapita":"11378股","listingDate":"2020-11-25","address":"浙江省台州市三门县浦坝港镇沿海工业城","registeredCapital":"11470万元","survey":" 浙江东亚药业股份有限公司的主营业务是化学原料药、医药中间体、化学制剂的研发、生产和销售业务。公司的主要产品是抗细菌类药物(β-内酰胺类和喹诺酮类)、消化系统药物、皮肤用抗真菌药物等。公司在浙江三门、浙江临海、江西九江建有一体化的制药基地,并在上海张江药谷、杭州下沙医药港小镇设有现代化的研发中心,先后获得“国家高新技术企业”“浙江省专利示范企业”“台州市管理创新十强企业”等称号。","listedPrice":31.13},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东亚药业(605177)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东亚药业(605177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东亚药业,605177,东亚药业股票,东亚药业股票老虎,东亚药业股票老虎国际,东亚药业行情,东亚药业股票行情,东亚药业股价,东亚药业股市,东亚药业股票价格,东亚药业股票交易,东亚药业股票购买,东亚药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东亚药业(605177)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东亚药业(605177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}